LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels

Photo by impulsq from unsplash

Key Points Question How common are payments from pharmaceutical companies and device manufacturers to gastroenterologists? Finding This cohort study of 15 497 gastroenterologists found that 86.9% received industry payments, with direct… Click to show full abstract

Key Points Question How common are payments from pharmaceutical companies and device manufacturers to gastroenterologists? Finding This cohort study of 15 497 gastroenterologists found that 86.9% received industry payments, with direct financial awards accounting for 62.7% of the total expenditures and 10 drugs accounting for 63.8% of the total payments. Twenty-nine of 36 recent guidelines included authors who had received industry payments. Meaning While mandated reporting of industry payments to physicians provides transparency, the practice remains common and may continue to affect the advice these physicians give to patients and peers.

Keywords: pharmaceutical company; assessment pharmaceutical; industry payments; device manufacturer; practice; company device

Journal Title: JAMA Network Open
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.